Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Proact - New targets include adj. EPS doubling 2025-30

11 november 2026

<a id="bm-comp-fa38948e-ca11-4cb7-837f-0b3f6ef1bfa5" name="bm-comp-fa38948e-ca11-4cb7-837f-0b3f6ef1bfa5" class="BMCustomAnchor"></a><table><tr><td bm-component-id="fa38948e-ca11-4cb7-837f-0b3f6ef1bfa5" style="vertical-align: top; width:100.000000%;"><ul><li>Sales and adj. EBITA margin targets unchanged, new target "2030 adj. EPS SEK &gt;20"</li><li>15% adj. EPS CAGR in target vs 5- and 10-year track records of 11%</li><li>21% upside to our 2028e adj. EPS based on the CAGR, M&amp;A and buybacks explain this</li></ul></td></tr></table><a id="bm-comp-68ff9ba4-b328-4005-bfe5-2330e65b3339" name="bm-comp-68ff9ba4-b328-4005-bfe5-2330e65b3339" class="BMCustomAnchor"></a><table><tr><td bm-component-id="68ff9ba4-b328-4005-bfe5-2330e65b3339" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Introdcuing an adj. EPS target of SEK &gt;20 by 2030</h3><p>Proact has released new financial targets ahead of the CMD later today (CET 13.30-17.30). Sales growth averaging 10% per year including M&amp;A and EBITA margin &gt;8% are unchanged. New target is to double adj. EPS between 2025-2030 meaning reaching &#8220;at least SEK 20 in adj. EPS 2030&#8221;. The adj. EPS growth implies 15% per year, vs 5-year and 10-year adj. EPS CAGR&#8217;s of 11% and our estimate of 8% between 2025-28e, meaning somewhat raised ambitions and 21% above our 2028e estimate (M&amp;A and buybacks main explanation). Net debt/EBITDA should also be between 1-2x by 2030 vs current 0x.</p><h3 class="bm-h3">Sales target likely the most demanding</h3><p>Main challenge will likely be to deliver on the growth target as last 10-year annual growth has only been 5%, hence it will be interesting to get more clarity on how to achieve this on the CMD today. The share currently trades at 11.5x adj. P/E on 2026-27e, using today&#8217;s multiples on 2030 adj. EPS would imply SEK 230/share (59% upside from current close, or 12% per year).</p></td></tr></table><a id="bm-comp-0bc1b723-45f8-47f6-800a-5ea0c5985b15" name="bm-comp-0bc1b723-45f8-47f6-800a-5ea0c5985b15" class="BMCustomAnchor"></a><table><tr><td bm-component-id="0bc1b723-45f8-47f6-800a-5ea0c5985b15" style="vertical-align: top; width:100.000000%;"><table id="bm-img-d35becf0-a414-454b-9313-60443d0c6080" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Adj. EPS per year and new target of SEK &gt;20 by 2030</td></tr><tr><td><img bm-img-encrypt="d35becf0-a414-454b-9313-60443d0c6080" bm-img-original-height="473" bm-img-original-width="794" bm-img-svg="image:image_upload/100491_f894472c-42b5-4135-8fde-7ac30a1f2a2d.svg" bm-img-width-hint="81.96%" id="bm-id-d35becf0-a414-454b-9313-60443d0c6080" src="https://abgsc.bluematrix.com/images/image_upload/100491_f894472c-42b5-4135-8fde-7ac30a1f2a2d_595.png" svg="/nas/web/clients/abgsc/images/image_upload/100491_f894472c-42b5-4135-8fde-7ac30a1f2a2d.svg" width="595" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, company data</td></tr></table></td></tr></table><a id="bm-comp-4834b863-2951-4ec0-9b49-71feeff4744b" name="bm-comp-4834b863-2951-4ec0-9b49-71feeff4744b" class="BMCustomAnchor"></a><table><tr><td bm-component-id="4834b863-2951-4ec0-9b49-71feeff4744b" style="vertical-align: top; width:100.000000%;"></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-11-19 Tempest Security - Growth returns but margins lag Tempest Sec.. Analys
2026-11-19 Coor - Restarts the M&A engine Coor Analys
2026-11-18 Eltel - CMD: Growth follows the margin repair Eltel Analys
2026-11-16 Petrolia Noco - Q3 impacted by underlift Petrolia Noco Analys
2026-11-16 Proact - CMD takeaways: Clear path to 2030 targets Proact Analys
2026-11-16 Donkey Republic - Wins 1,700-bike Karlsruhe contract Donkey Repu.. Analys
2026-11-16 Ogunsen - Back to growth with a leaner base Ogunsen Analys
2026-11-15 Isofol Medical - Clinical momentum builds ahead o... Isofol Medical Analys
2026-11-13 Clavister - Scaling up with civilian business nex... Clavister Analys
2026-11-12 Generic - Seasonality in volumes with margins hol... Generic Analys
2026-11-12 Xplora Technologies - Strong beat, but shouldn't ... Xplora Tech.. Analys
2026-11-12 Clavister - Scalability on full display Clavister Analys
2026-11-12 Generic - Softer growth but stronger earnings Generic Analys
2026-11-11 Ferronordic - The new normal Ferronordic Analys
2026-11-11 Proact - New targets include adj. EPS doubling 20... Proact Analys
2026-11-11 Ferronordic - Positive trend continues Ferronordic Analys
2026-11-10 Proact - Ahead of CMD Proact Analys
2026-11-10 G5 Entertainment - Estimates raised on lower costs G5 Entertai.. Analys
2026-11-10 Coor - Momentum building in Norway Coor Analys
2026-11-09 Generic - A broader base to grow from Generic Analys